University of Bristol Selects Signant Health’s TrialConsent for Oncology Trial
Yourway Mitigates Uncertainty of Brexit
Pratia Teams with VirTrial to Become ‘Virtual Trial Capable’
Informa Pharma Intelligence Launches Citeline Engage
3 Critical Challenges: Fulfilling the Promise of Precision Oncology
Executive Medical Director of Oncology for Premier Research, Emile Youssef, discusses crucial challenges that must be addressed in order to fulfill the promise of precision oncology.
Datacubed Health Launches Location Solution
PFF Launches Drug Development Pipeline Tool
Parexel Partners with HealthVerity
Pharma Companies Use AI to Advance Drug Development
BioXcel Therapeutics Executives, Vimal Mehta and Vince O’Neill, discuss how they are actively using artificial intelligence to discover advanced therapies in CNS and oncology.
Veeva Announces Free eRegulatory Solution
The Critical Importance of Real-Time Access to Clinical Study Performance
The need to see real-time study performance is vital, as teams focus on meeting timelines and ensuring resources are appropriately allocated, writes EVP of WCG, Jonathan Zung.
Who’s Going to be Disrupted by Shifts in European Health Strategy?
Peter O’Donnell writes of the support of ‘disruptive’ change in European health systems from European health professionals and policymakers from a recent gathering.
Elligo Receives FDA Grant
The ‘Quest’ for an Effective Partner in Pharma and Biotech
David Freeman, General Manager, Information Ventures, for Quest Diagnostics, discusses how his company can be an effective partner for pharma and biotech firms.
Operational Complexity in Cell and Gene Therapy Trials
As advanced therapy technology and manufacturing evolve, there are three key operational challenges to address unique to these products.
Alzheimer’s Research Finds New Beginnings
Despite mounting frustrations in drug R&D for Alzheimer's disease, emerging biopharma firms are still pursuing AD therapies with new science, and different preclinical and clinical trial models.
Eliminating ‘Disruption’ for Patients in Clinical Trials
Exploring new ways to smooth the path toward better participation for patients and other research and healthcare stakeholders.
Data Manipulation Case Spotlights Wider Concerns, Actions
Regulatory enforcement actions, policy updates, and new guidelines show that ensuring the reliability of clinical data is an ongoing priority.
Applied Clinical Trials, October 2019 Issue (PDF)
Click the title above to open the Applied Clinical Trials October 2019 issue in an interactive PDF format.
Patient Experience Comes to Drug Development
The transformation in patient perceptions will only happen when the five million Americans who’ve already participated in clinical trials can directly share their experiences with the next five million people considering participating.
Industry Report on Outsourcing Spend, Models, and Measures
A look at the findings from Avoca Group’s 2018 industry research survey on clinical outsourcing.
Fighting High Prices for Innovative Drugs with NHS Generic Production
A strongly-worded plan for reining-in profit-driven drug firms receives immediate backlash as arguments over drug pricing and patient access continue to rage around Europe and the US.
